Whole Shine Medical Technology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ning Ding

Chief executive officer

CN¥533.0k

Total compensation

CEO salary percentage	n/a
CEO tenure	2.3yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	3.8yrs

Recent management updates

Recent updates

CEO

Ning Ding (41 yo)

2.3yrs

Tenure

CN¥533,000

Compensation

Mr. Ning Ding serves as General Manager of Whole Shine Medical Technology Co., Ltd. since March 04, 2022.

Board Members

Name	Position	Tenure	Compensation	Ownership
Zhuang Miao	Chairman of the Supervisory Board	3.8yrs	no data	no data
Lu Lu	Chairman	5.3yrs	CN¥1.20m	no data
Zhanbin Niu	Non-Independent Director	3.8yrs	no data	no data
Yuting Tuo	Non-Independent Director	3.8yrs	no data	no data
Guigang Pan	Non-Independent Director	3.8yrs	no data	no data
Xin Qiu	Independent Director	3.8yrs	CN¥126.00k	no data
Lin Jiang	Independent Director	3.8yrs	CN¥126.00k	no data
Yawei Chen	Independent Director	3.8yrs	CN¥126.00k	0.00036% CN¥ 4.3k
Gujia Zhu	Director	no data	no data	no data

3.8yrs

Average Tenure

42.5yo

Average Age

Experienced Board: 002622's board of directors are considered experienced (3.8 years average tenure).

Whole Shine Medical Technology Management

Management criteria checks 2/4

Key information

Recent management updates

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 20, 2024

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 23, 2023

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

New minor risk - Share price stability

New minor risk - Financial data availability

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 20, 2024

New minor risk - Share price stability

Whole Shine Medical Technology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Now 23% undervalued after recent price drop

Now 28% undervalued after recent price drop

Now 26% undervalued after recent price drop

Whole Shine Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.02 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.011 (vs CN¥0.006 loss in 2Q 2022)

Whole Shine Medical Technology Co., Ltd., Annual General Meeting, May 23, 2023

First quarter 2023 earnings released: CN¥0.001 loss per share (vs CN¥0.03 loss in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.008 loss in 3Q 2021)

Rongyu Group Co., Ltd. announced that it expects to receive CNY 652 million in funding

Second quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.015 profit in 2Q 2021)

First quarter 2022 earnings released: CN¥0.03 loss per share (vs CN¥0.004 loss in 1Q 2021)

High number of new and inexperienced directors

Third quarter 2021 earnings released: CN¥0.008 loss per share (vs CN¥0.006 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.015 (vs CN¥0.038 loss in 2Q 2020)

Rongyu Group Co., Ltd. (SZSE:002622) signed a framework agreement to acquire 52% stake in Guangzhou Delun Medical Investment Co., Ltd. from Gongqingcheng Delun Medical Investment Management Partnership (Limited Partnership).

Rongyu to Buy 67% Stake in Healthcare Firm for Up to 441.5 Mln Yuan

Full year 2020 earnings released: CN¥0.34 loss per share (vs CN¥0.009 profit in FY 2019)

New 90-day low: CN¥2.13

New 90-day low: CN¥2.79

New 90-day high: CN¥3.63

Third quarter earnings released

New 90-day low: CN¥3.03

First half earnings released

Rongyu Group Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age